P2X 7 receptors stimulate AKT phosphorylation in astrocytes

British Journal of Pharmacology

Volumn 141, Issue 7, 2004, Pages 1106-1117

  Jacques Silva, Maria C ^a   Rodnight, Richard ^a   Lenz, Guido ^a   Liao, Zhongji ^b   Kong, Qiongman ^b   Tran, Minh ^c   Kang, Yuan ^c   Gonzalez, Fernando A ^d   Weisman, Gary A ^b   Neary, Joseph T ^c,e  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b University of Missouri   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Akt; Astrocytes; BzATP; c Src; Calcium; P2X 7; PI3K; Purinergic receptors

Indexed keywords

2',3' O (4 BENZOYL)BENZOYL ADENOSINE TRIPHOSPHATE; ISOPYRIDOXAL 5' PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PURINE ANTAGONIST; PURINE DERIVATIVE; PURINE P2X RECEPTOR; PURINE P2X RECEPTOR AGONIST; PURINE P2X RECEPTOR ANTAGONIST; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR AGONIST; UNCLASSIFIED DRUG; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AKT1 PROTEIN, HUMAN; AKT1 PROTEIN, RAT; CALCIUM; DRUG DERIVATIVE; GLUTAMIC ACID; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PURINE P2 RECEPTOR; PURINE P2X2 RECEPTOR; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG SPECIFICITY; EXTRACELLULAR CALCIUM; GENETIC TRANSFECTION; NEWBORN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REDUCTION; SIGNAL TRANSDUCTION; STIMULATION; ANIMAL; CELL CULTURE; CLASSIFICATION; DOSE RESPONSE; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; ANIMALS; ASTROCYTES; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; URIDINE TRIPHOSPHATE;

EID: 2342469938     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705685     Document Type: Article

References (76)

1. ABBRACCHIO, M.P., BOEYNAEMS, J.M., BARNARD, E.A., BOYER, J.L., KENNEDY, C., MIRAS-PORTUGAL, M.T., KING, B.F., GACHET, C., JACOBSON, K.A., WEISMAN, G.A. & BURNSTOCK, G. (2003). Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci., 24, 52-55.
2. ABBRACCHIO, M.P. & BURNSTOCK, G. (1994). Purinoreceptors: are there families of P2X and P2Y purinoreceptors? Pharmac. Ther., 64, 445-475.
3. BAUER, B., JENNY, M., FRESSER, F., ÜBERALL, F. & BAIER, G. (2003). Akt1/PKBα is recruited to lipid rafts and activated downstream of PKC isotypes in CD3-induced T cell signalling. FEBS Lett., 541, 155-162.
4. BEIGI, R.D., KERTESY, S.B., AQUILINA, G. & DUBYAK, G.R. (2003). Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br. J. Pharmacol., 140, 507-519.
5. BIANCHI, B.R., LYNCH, K.J., TOUMA, E., NIFORATOS, W., BURGARD, E.C., ALEXANDER, K.M., PARK, H.S., YU, H., METZGER, R., KOWALUK, E., JARVIS, M.F. & VAN BIESEN, T. (1999). Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol., 376, 127-138.
6. BO, X., ZHANG, Y., NASSAR, M., BURNSTOCK, G. & SCHOEPFER, R. (1995). A P2X purinoreceptor cDNA conferring a novel pharmacological profile. FEBS Lett., 375, 129-133.
7. BRAMBILLA, R., NEARY, J.T., CATTABENI, F., COTTINI, L., D'IPPOLITO, G., SCHILLER, P.R. & ABBRACCHIO, M.P. (2002). Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. J. Neurochem., 83, 1285-1296.
8. 1/2 pathway. Drug Dev. Res., 59, 161-170.
9. BRAZIL, D.P. & HEMMINGS, B.A. (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci., 26, 657-664.
10. 2-vitamin D3 signalling to the nucleus in muscle cells. Biochim. Biophys. Acta, 1541, 179-187.
11. CANTRELL, D.A. (2001). Phosphoinositide 3-kinase signaling pathways. J. Cell Sci., 114, 1439-1445.
12. CHAN, T.O. & TSICHILIS, P.N. (2001). PDK2: a complex tail in one Akt. Science's STKE, 66, 1-5.
13. CHEN, R., KIM, O., YANG, J., SATO, K., EISENMANN, K.M., MCCARTHY, J., CHEN, H. & QIU, Y. (2001). Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem., 276, 31858-31862.
14. COMMUNI, D., ROBAYE, B. & BOEYNAEMS, J. (1999). Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol., 128, 1199-1206.
15. CROSS, T.G., SCHEEL-TOELLNER, D., HENRIQUEZ, N.V., DEACON, E., SALMON, M. & LORD, J.M. (2000). Serine/threonine protein kinases and apoptosis. Exp. Cell Res., 256, 34-41.
16. DI VIRGILIO, F. (2003). Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target. Br. J. Pharmacol., 140, 441-443.
17. DI VIRGILIO, F., CHIOZZI, P., FALZONI, S., FERRARI, D., SANZ, J.M., VENKETARAMAN, V. & BARICORDI, O.R. (1998). Cytolytic P2X receptors. Cell Death Differ., 5, 191-199.
18. D'ONOFRIO, M., CUOMO, L., BATTAGLIA, G., NGOMBA, R.T., STORTO, M., KINGSTON, A.E., ORZI, F., DE BLASI, A., DI IORIO, P., NICOLETTI, F. & BRUNO, V. (2001). Neuroprotection mediated by glial group II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J. Neurochem., 78, 435-445.
19. DOWNWARD, J. (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol., 10, 262-267.
20. DUAN, S., ANDERSON, C.M., KEUNG, E.C., CHEN, Y. & SWANSON, R.A. (2003). P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci., 23, 1320-1328.
21. o-mediated signal transduction. J. Cell Biol., 153, 491-501.
22. ERB, L., LUSTIG, K.D., AHMED, A.H., GONZALEZ, F.A. & WEISMAN, G.A. (1990). Covalent incorporation of 3′-O-(4-benzoyl)benzoyl-ATP into a P2 purinoreceptor in transformed mouse fibroblasts. J. Biol. Chem., 265, 7424-7431.
23. EVANS, R.J., LEWIS, C., BUELL, G., NORTH, R.A. & SURPRENANT, A. (1995). Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X-purinoreceptors). Mol. Pharmacol., 48, 178-183.
24. FRANKE, H., GROSCHE, J., SCHÄDLICH, H., KRÜGEL, U., ALLGAIER, C. & ILLES, P. (2001). P2X receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience, 108, 421-429.
25. FRUMAN, D.A., MEYERS, R.E. & CANTLEY, L.C. (1998). Phosphoinositide kinases. Annu. Rev. Biochem., 67, 481-507.
26. 2 nucleotide receptor: consequences of truncation of the C-terminus. J. Biol. Chem., 273, 29437-29444.
27. + channels in rat hippocampal astrocytes. J. Neurosci., 23, 1678-1687.
28. 7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Cell Physiol., 284, C571-C581.
29. 7 nucleotide receptors that mediate neuroinflammatory responses in astrocytes and microglial cells. Biomedical Res., 14, 47-61.
30. GERVITZ, L.M., NALBANT, D., WILLIAMS, S.C. & FOWLER, J.C. (2002). Adenosine-mediated activation of Akt/protein kinase B in the rat hippocampus in vitro and in vivo. Neurosci. Lett., 328, 175-179.
31. GLIKI, G., WHEELER-JONES, C. & ZACHARY, I. (2002). Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol-3-kinase-mediated PKCδ phosphorylation: role of PKC in angiogenesis. Cell Biol. Int., 26, 751-759.
32. GONZALEZ, F.A., AHMED, A.H., LUSTIG, K.D., ERB, L. & WEISMAN, G.A. (1989). Permeabilization of transformed mouse fibroblasts by 3′-O-(4-benzoyl)benzoyl adenosine 5′-triphosphate and the desensitization of the process. J. Cell. Physiol., 139, 109-115.
33. HANKE, J.H., GARDNER, J.P., DOW, R.L., CHANGELIAN, P.S., BRISSETTE, W.H., WERINGER, E.J., POLLOCK, B.A. & CONNELLY, P.A. (1996). Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J. Biol. Chem., 271, 695-701.
34. 7 receptor orthologs. J. Pharmacol. Exp. Ther., 296, 947-957.
35. 7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol. Pharmacol., 54, 22-32.
36. 2 purinoreceptor in renal mesangial cells. Br. J. Pharmacol., 136, 520-529.
37. IACOVELLI, L., BRUNO, V., SALVATORE, L., MELCHIORRI, D., GRADINI, R., CARICASOLE, A., BARLETTA, E., DE BLASI, A. & NICOLETTI, F. (2003). Native group III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol 3-kinase pathways. J. Neurochem., 82, 216-223.
38. 7 receptors. Mol. Pharmacol., 58, 82-88.
39. KHAKH, B., BURNSTOCK, G., KENNEDY, C., KING, B.F., NORTH, R.A., SÉGUÉLA, P., VOIGT, M. & HUMPHREY, P.P.A. (2001). International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev., 53, 107-118.
40. 7 receptor signaling complex. EMBO J., 20, 6347-6358.
41. 7 receptor in immune cells of the brain and periphery. J. Biol. Chem., 276, 23262-23267.
42. KING, B.F., NEARY, J.T., ZHU, Q., WANG, S., NORENBERG, M.D. & BURNSTOCK, G. (1996). P2 purinoreceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies. Neuroscience, 74, 1187-1196.
43. 2 receptor. Br. J. Pharmacol., 121, 1445-1453.
44. KODAKI, T., WOSCHOLSKI, R., HALLBERG, B., RODRIGUEZ-VICIANA, P., DOWNWARD, J. & PARKER, P.J. (1994). The activation of phosphatidylinositol 3-kinase by Ras. Curr. Biol., 4, 798-806.
45. KUKLEY, M., BARDEN, J.A., STEINHAUSER, C. & JABS, R. (2001). Distribution of P2X receptors on astrocytes in juvenile rat hippocampus. Glia, 36, 11-21.
46. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
47. LENZ, G., GOTTFRIED, C., LUO, Z., AVRUCH, J., RODNIGHT, R., NIE, W., KANG, Y. & NEARY, J.T. (2000). P2Y purinoreceptor subtypes recruit different Mek activators in astrocytes. Br. J. Pharmacol., 129, 927-936.
48. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature, 377, 432-435.
49. LEWIS, C., SURPRENANT, A. & EVANS, R.J. (1998). 2′,3′-O- (2,4,6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP) - a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels. Br. J. Pharmacol., 124, 1463-1466.
50. MARTINY-BARON, G., KAZANIETZ, M.G., MISCHAK, H., BLUMBERG, P.M., KOCHS, G., HUG, H., MARME, D. & SCHACHTELE, C (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem., 268, 9194-9197.
51. MOTLEY, E.D., EGUCHI, K., GARDNER, C., HICKS, A.L., REYNOLDS, C.M., FRANK, G.D., MIFUNE, M., OHBA, M. & EGUCHI, S. (2003). Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-α. Hypertension, 41, 775-780.
52. 2Z receptor. J. Biol. Chem., 268, 8199-8203.
53. NEARY, J.T., BAKER, L., JORGENSEN, S.L. & NORENBERG, M.D. (1994a). Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol., 87, 8-13.
54. NEARY, J.T., KANG, Y., BU, Y., YU, B., AKONG, K. & PETERS, C.M. (1999). Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol- specific phospholipase C/calcium pathway. J. Neurosci., 19, 4211-4220.
55. NEARY, J.T., RATHBONE, M.P., CATTABENI, F., ABBRACCHIO, M.P. & BURNSTOCK, G. (1996). Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci., 19, 13-18.
56. NEARY, J.T., WHITTEMORE, S.R., ZHU, Q. & NORENBERG, M.D. (1994b). Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factor and extracellular ATP. J. Neurochem., 63, 490-494.
57. NEARY, J.T. & ZHU, Q. (1994). Signaling by ATP receptors in astrocytes. NeuroReport, 5, 1617-1620.
58. NORTH, R.A. (2002). Molecular physiology of P2X receptors. Physiol. Rev., 82, 1013-1067.
59. Cas tyrosine phosphorylation requires calcium-dependent c-Src activation. J. Biol. Chem., 274, 26803-26809.
60. PANENKA, W., JIJON, H., HERX, L.M., ARMSTRONG, J.N., FEIGHAN, D., WEI, T., YONG, V.W., RANSOHOFF, R.M. & MACVICAR, B.A. (2001). P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci., 21, 7135-7142.
61. 2U nucleotide receptor: a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. U.S.A., 91, 3275-3279.
62. 2+-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphatidylinositol 3-kinase-dependent stimulation of the mitogen-activated protein kinase signaling cascade in neurons. J. Neurosci., 19, 5861-5874.
63. PETERSON, G.L. (1983). Determination of total protein. Methods Enzymol., 91, 95-119.
64. RALEVIC, V. & BURNSTOCK, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
65. SCHULTE, G. & FREDHOLM, B.B. (2002). Signaling pathway through the human adenosine A3 receptor expressed in Chinese hamster ovary cells to the extracellular-signal regulated kinase 1/2. Mol. Pharmacol., 62, 1137-1146.
66. 7 receptors. Am. J. Physiol., 275, F962-971.
67. SEGER, R. & KREBS, E.G. (1995). The MAPK signaling cascade. FASEB J., 9, 726-735.
68. SHIBUYA, I., TANAKA, K., HATTORI, Y., UEZONO, Y., HARAYAMA, N., NOGUCHI, J., UETA, Y., IZUMI, F. & YAMASHITA, H. (1999). Evidence that multiple P2X purinoreceptors are functionally expressed in the rat supraoptic neurons. J. Physiol., 514, 351-367.
69. 7 receptors. J. Neurochem., 73, 334-343.
70. 7). Science, 272, 735-738.
71. TANAKA, Y., GAVRIELIDES, M.V., MITSUUCHI, Y., FUJII, T. & KAZANIETZ, M.G. (2003). Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through the activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem., 278, 33753-33762.
72. VALERA, S., HUSSY, N., EVANS, R.J., ADAMI, N., NORTH, R.A., SURPRENANT, A. & BUELL, G. (1994). A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature, 371, 516-519.
73. VIRGINIO, C., MACKENZIE, A., NORTH, R.A. & SURPRENANT, A. (1999). Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J. Physiol., 519, 335-346.
74. 2/3 receptors. Mol. Pharmacol., 53, 969-973.
75. YANO, S., TOKUMITSU, H. & SODERLING, T.R. (1998). Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature, 396, 584-587.
76. ZIMMERMANN, H. (2001). Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev. Res., 52, 44-56.